FR2361414A1 - IMMUNITY DETERMINATION PROCESS USING NEW IMMUNOCHEMICAL COMPOUNDS - Google Patents

IMMUNITY DETERMINATION PROCESS USING NEW IMMUNOCHEMICAL COMPOUNDS

Info

Publication number
FR2361414A1
FR2361414A1 FR7713206A FR7713206A FR2361414A1 FR 2361414 A1 FR2361414 A1 FR 2361414A1 FR 7713206 A FR7713206 A FR 7713206A FR 7713206 A FR7713206 A FR 7713206A FR 2361414 A1 FR2361414 A1 FR 2361414A1
Authority
FR
France
Prior art keywords
determination process
compounds
immunochemical
immunity determination
immunity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7713206A
Other languages
French (fr)
Other versions
FR2361414B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beckman Coulter Inc
Original Assignee
Beckman Instruments Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/682,807 external-priority patent/US4081244A/en
Priority claimed from US05/682,808 external-priority patent/US4081245A/en
Priority claimed from US05/682,830 external-priority patent/US4081246A/en
Application filed by Beckman Instruments Inc filed Critical Beckman Instruments Inc
Publication of FR2361414A1 publication Critical patent/FR2361414A1/en
Application granted granted Critical
Publication of FR2361414B1 publication Critical patent/FR2361414B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/539—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
    • G01N33/541—Double or second antibody, i.e. precipitating antibody

Abstract

L'invention concerne un composé immunochimique pour séparer des fractions libres de fractions liées dans un processus de détermination d'immunité du type ayant une matrice de polysaccharide ou dérivés couplée de façon covalente à un anticorps par un agent couplant bifonctionneL Selon l'invention, l'agent couplant bifonctionnel est choisi dans un groupe consistant en :The invention relates to an immunochemical compound for separating free fractions from bound fractions in an immunity determination process of the type having a polysaccharide or derivative matrix covalently coupled to an antibody by a bifunctional coupling agent. The bifunctional coupling agent is selected from a group consisting of:

FR7713206A 1976-05-03 1977-05-02 IMMUNITY DETERMINATION PROCESS USING NEW IMMUNOCHEMICAL COMPOUNDS Granted FR2361414A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US05/682,807 US4081244A (en) 1976-05-03 1976-05-03 Immunoassay procedure employing novel immunochemical composites
US05/682,808 US4081245A (en) 1976-05-03 1976-05-03 Immunoassay procedure employing novel immunochemical composites
US05/682,830 US4081246A (en) 1976-05-03 1976-05-03 Solid phase column immunoassay procedure employing novel immunochemical composites

Publications (2)

Publication Number Publication Date
FR2361414A1 true FR2361414A1 (en) 1978-03-10
FR2361414B1 FR2361414B1 (en) 1982-11-19

Family

ID=27418405

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7713206A Granted FR2361414A1 (en) 1976-05-03 1977-05-02 IMMUNITY DETERMINATION PROCESS USING NEW IMMUNOCHEMICAL COMPOUNDS

Country Status (10)

Country Link
JP (1) JPS52134020A (en)
AU (1) AU510210B2 (en)
CH (1) CH629894A5 (en)
DE (1) DE2719772A1 (en)
ES (1) ES458411A1 (en)
FR (1) FR2361414A1 (en)
GB (1) GB1588253A (en)
IT (1) IT1081386B (en)
NL (1) NL7704784A (en)
NZ (1) NZ183970A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54147913A (en) * 1978-05-12 1979-11-19 Unitika Ltd Preparation of immunoadsorbent
FR2459479B1 (en) * 1979-06-21 1983-07-08 Inst Nat Sante Rech Med PROCESS FOR SEPARATING A PROTEIN SUBSTANCE FROM A SOLUTION CONTAINING IT BY AFFINITY FILTRATION AND APPLICATION OF SAID METHOD FOR ENZYMATIC ASSAYS
DE3019163C2 (en) 1980-05-20 1984-07-26 B.A.T. Cigaretten-Fabriken Gmbh, 2000 Hamburg Use of cellulose fibers containing amino groups as a material for tobacco smoke filters
US4778751A (en) * 1986-05-12 1988-10-18 Diagnostic Products Corporation Method for measuring antigens or antibodies in biological fluids using ligand labeled antigens or ligand labeled antibodies
DE4140142A1 (en) * 1991-12-05 1993-06-09 Boehringer Mannheim Gmbh, 6800 Mannheim, De MULTIVALENT DEXTRANREAGENT FOR USE IN PRECIPITATION TESTS
DE4229378A1 (en) * 1992-09-03 1994-03-10 Daimler Benz Ag Tube-section union with adhesive components - comprises segments alternately overlapping adjacent sections, adhesion being by hook-pile fasteners butting together

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867366A (en) * 1972-11-06 1975-02-18 Synvar Associates A K A Syva C Opiate imidates and protein conjugates thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867366A (en) * 1972-11-06 1975-02-18 Synvar Associates A K A Syva C Opiate imidates and protein conjugates thereof

Also Published As

Publication number Publication date
GB1588253A (en) 1981-04-23
JPS52134020A (en) 1977-11-09
AU510210B2 (en) 1980-06-12
IT1081386B (en) 1985-05-21
CH629894A5 (en) 1982-05-14
AU2471977A (en) 1978-11-02
NZ183970A (en) 1979-06-08
NL7704784A (en) 1977-11-07
ES458411A1 (en) 1978-12-01
DE2719772A1 (en) 1977-11-24
FR2361414B1 (en) 1982-11-19

Similar Documents

Publication Publication Date Title
Izui et al. Selective suppression of retroviral gp70-anti-gp70 immune complex formation by prostaglandin E1 in murine systemic lupus erythematosus.
FR2409253A1 (en) CARBOXYL ESTER PRODUCTION PROCESS
NO20073429L (en) Use of an antibody against interleukin-6 receptor for the preparation of a pharmaceutical composition
EP0069678A3 (en) 3-fucosyl-n-acetyl-lactosamine derivatives, their preparation and their biological applications
KR930701169A (en) 3-phenyl-5,6-dihydrobenz [C] acridine-7-carboxylic acid and related compounds as immunosuppressive agents
Critchley et al. Characterization of the cholera toxin receptor on Balb/c 3T3 cells as a ganglioside similar to, or identical with, ganglioside GM1. No evidence for galactoproteins with receptor activity
CA2172663A1 (en) Improved reagents for a cannabinoid immunoassay
Bruijn et al. Anti-basement membrane glomerulopathy in experimental trypanosomiasis.
FR2361414A1 (en) IMMUNITY DETERMINATION PROCESS USING NEW IMMUNOCHEMICAL COMPOUNDS
Leskowitz et al. Immunochemical Studies on Blood Groups. XV. The Effect of Mild Acid Hydrolysis on the Glucosamine and Galactosamine in Blood Group Substances1
Mardiney Jr et al. Ultrastructural localization of the third and fourth components of complement on complement-cell complexes.
CA2071904A1 (en) Antibodies to ligand analogues and their utility in ligand-receptor assays
Cookson et al. Structural homology of cytochromes c
FR2394604A1 (en) GRANULAR OR PULVERULENT DETERGENT COMPOSITION OF HIGH FLUIDITY
ES2070820T3 (en) MONOCLONAL ANTIBODIES SPECIFIC TO APOLIPOPROTEIN B, PRODUCED BY TWO NEW HYBRIDOMES.
Teague et al. Changes in monosaccharide content of mucous glycoproteins in ulcerative colitis
Okuda et al. Deposition of autologous gamma globulin in kidneys of rats with nephrotic renal disease of various etiologies
Taylor et al. The distribution of administered vitamin K1-C14 in rats
FR2457140A1 (en) COMPOSITION FOR FOUNDRY CORES OR MOLDS CONTAINING CERTAIN FULVENE-LIKE BINDERS, SUCH NEW BINDERS, AND METHODS OF PREPARING THE SAME
Anderson et al. Polymer modification of antibody to eliminate immune complex and Fc binding
Schlesinger et al. A distinctive form of soluble CD8 is secreted by stimulated CD8+ cells in HIV-1-infected and high-risk individuals
Bruyn et al. 1H NMR Study of Methyl O-Acetyl-α-and-β-D-Xylopyranosides Conformational Studies and Non Additivity of 1H-Shift Increments
DE59105603D1 (en) MONOCLONAL ANTIBODIES AGAINST THE INTERLEUKIN 2 RECEPTOR.
Weidner et al. Characterization of interactions involving anti-metatype antibodies and immune complexes
Warner et al. Detection of two species of antibody molecules with the same specificity

Legal Events

Date Code Title Description
ST Notification of lapse